Redeye: Railcare - On Track in Q1
Redeye is only making minor adjustments to our financial forecasts following the Q1 report. Market conditions and outlook remain favorable, and we expect Railcare to show a more stable performance during the current year compared to the rather bumpy 2021. We are now applying a higher WACC which has some negative impact on valuation, but still see an appealing potential in the share.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/